Noel and Nord are spending $1.2 billion to build a U.S. plant and create an additional 700 jobs

You're not mistaken! On August 26th Noel and Nord announced a $1.2bn investment in a PLANT in the US, with an estimated 700 employees, and in the US, Norfox will also build a plant in Denmark for $800m. The whole project will last five years.
the U.S., Noor and Nord will have their plants located in the Clayton area of Southern California. The site already has No. 1 and Nord plants that produce pre-filled insulin (for the U.S. market only) and is involved in packaging. With the addition of a new plant, No. 1 and Nord's U.S. production workforce is likely to double.
did you choose to build a plant in the United States? Noor and Nord give three answers:
is to get their products on the market. On July 13th Novo Norfoe's first oral long-acting GLP-1 similar, Somalutide, achieved positive results in Phase IIIa clinical trials, adding new additions to the GLP-1 sugar-lowering drug in novo Nord's diabetes pipeline, which combines sugar-lowering and weight-loss benefits. The product, which was previously a weekly dosage form of sultrain injection, has been developed as a daily oral product. The product will complete clinical studies covering 8,000 patients by next year, No.
that the U.S. plant will produce Somaglutide raw materials and active ingredients. The plant in Denmark will add about 100 jobs while producing oral preparations and other oral products for Somaglutide. The company said the move would eliminate concerns about its API production capacity for the next decade.
, the Clayton area of the United States is really suitable for No. "The U.S. market brings about half of No. Clayton was chosen because not only do it have good facilities, but 20 percent of its employees have been soldiers and fit to work for the company, and the company will benefit from incentives provided by the U.S. government, iland said.
is to solve the foreign exchange problem: it is understood that this will reduce foreign exchange risk by about $850m a year to achieve hedging. Although the initial investment of $1.2 billion, but foreign exchange alone can recover most of the sales, not to mention oral products on the market. (Bio Valley)